Micell Technologies

company

About

Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$7M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 1995
Number Of Employee
1 - 10
Operating Status
Active

Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$23M
Micell Technologies has raised a total of $23M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2009 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2009 Series B $15M 1 Detail
Jul 12, 2007 Series A $7M 1 Invemed Catalyst Fund Detail
Jul 18, 2002 Series Unknown $1M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Micell Technologies is funded by 2 investors. Invemed Catalyst Fund and Gladwyne Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Invemed Catalyst Fund Series B
Gladwyne Partners Series Unknown